Thrombopoietin-receptor agonists in children with immune thrombocytopenia

Lancet. 2015 Oct 24;386(10004):1606-9. doi: 10.1016/S0140-6736(15)61223-5. Epub 2015 Jul 28.

Authors

Cindy E Neunert¹, Rachael F Grace²

Affiliations

¹ Department of Pediatrics Hematology/Oncology/Bone Marrow Transplant, Columbia University, New York, NY 10032, USA. Electronic address: cn2401@cumc.columbia.edu.
² Department of Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorder Center, Boston, MA, USA.

PMID: 26231462
DOI: 10.1016/S0140-6736(15)61223-5

No abstract available

Publication types

Comment

MeSH terms

Benzoates / therapeutic use*
Female
Humans
Hydrazines / therapeutic use*
Male
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Pyrazoles / therapeutic use*
Receptors, Thrombopoietin / agonists*

Substances

Benzoates
Hydrazines
Pyrazoles
Receptors, Thrombopoietin